Fragrances Related News

Evolva teams up with FCI to expand nootkatone and valencene sales & marketing in Europe

16 March 2017 – Evolva  announces that it is teaming up with Paris-based FCI to expand the European sales, marketing and distribution of its high-purity, sustainably sourced citrus ingredients, nootkatone and valencene. Nootkatone is a molecule that gives grapefruit its [...]

By | March 20th, 2017|Consumer Products & Manufacturing, Food, Fragrances, News|

Evolva achieves second milestone in fragrance & flavour alliance with Takasago

9 March 2017 – Evolva (SIX: EVE) today announces reaching the second technical milestone under the multi-year R&D alliance with Takasago. This achievement brings the project closer to the launch of the target ingredients and prompts a total milestone payment [...]

By | March 9th, 2017|Consumer Products & Manufacturing, Fragrances, News|

Renewable Energy Group Unveils First Commercial Product in Transaction with Aroma Chemical Services

Renewable Energy Group (REG) Life Sciences has announced the delivery of its first commercial chemical product to Aroma Chemical Services (ACS) International.  The two companies have been collaborating on the development and commercialization of specialty flavor and fragrance chemicals by [...]

By | November 2nd, 2016|Consumer Products & Manufacturing, Fragrances, News|

REG Delivers First Life Sciences Commercial Product

Oct 31, 2016 Specialty Fatty Acid to Be Used By Leading Fragrance Manufacturer NOTE:  A video on this topic can be viewed at this link:  https://youtu.be/Y6L3rcocbUI (AMES, IA)—REG Life Sciences, LLC, a wholly owned subsidiary of Renewable Energy Group (NASDAQ: [...]

Amyris & Ginkgo Bioworks Complete Collaboration Agreement to Accelerate Commercialization of Bio-Based Products

EMERYVILLE, Calif. and BOSTON, Sept. 15, 2016 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has completed a subsequent collaboration agreement with Ginkgo Bioworks, which is expected to be approved by the boards of [...]

3 Potential New Molecules for Amyris’ Portfolio in 2014

Synthetic biology pioneer Amyris may have spent much of last year slashing wasteful spending and reevaluating its strategic vision, but it also achieved several major farnesene production milestones at its lone commercial facility in Brotas, Brazil. While the company will continue to [...]